Cytokinetics Inc
CYTKCIK 0001061983 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
19,612 bought / 27,112 sold
net −7,500 sh · −$1.89M
- buys
- 3
- sells
- 4
- insiders active
- 4
Filing tape
Filed Tue, Jul 7, 2026
- −0 sh · $275.9K
Malik Fady Ibraham — EVP Research & Development
- Exercised3,500Common Stock@ $7.80→ 157,402 held
- Sold3,500Common Stock@ $86.62→ 153,902 held
- Exercised3,500Non-Qualified Stock Option (Right to Buy)→ 37,386 held
Filed Thu, Jul 2, 2026
- −7,500 sh · $636.9K
Blum Robert I — President & CEO · Director
- Sold7,500Common Stock@ $84.92→ 377,830 held
- −0 sh · $938.1K
Callos Andrew — EVP, Chief Commercial Officer
- Exercised15,000Common Stock@ $23.26→ 73,555 held
- Sold15,000Common Stock@ $85.80→ 58,555 held
- Exercised15,000Non-Qualified Stock Option (Right to Buy)→ 24,000 held
- −0 sh · $43.7K
Lee Sung — EVP, Chief Financial Officer
- Exercised1,112Common Stock@ $48.51→ 64,333 held
- Sold1,112Common Stock@ $87.79→ 63,221 held
- Exercised1,112Non-Qualified Stock Option (Right to Buy)→ 26,709 held
Insiders on this tape
- Malik Fady IbrahamEVP Research & Development
- Blum Robert IPresident & CEO · Director
- Callos AndrewEVP, Chief Commercial Officer
- Lee SungEVP, Chief Financial Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.